Carl Zeiss Meditec Reports Loss: What Does the China Crisis Mean for Jena?
Carl Zeiss Meditec has slipped into the red, reporting a €4.9 million loss in its first fiscal quarter. As currency fluctuations and shifting procurement rules in China impact the MDAX-listed company, questions arise about the future of its headquarters in Jena. With a strategic pivot toward local production in China looming, the medical technology giant faces a challenging year of transformation.